IGF1 and acromegaly: Falch et al. (2023) in a registry of 178 patients with acromegaly followed for 12 months between 2005-2020 observed that IGF-1 normalization was a predictor of biochemical control in short-term surgical patients, they also found greater biochemical control in patients treated with drugs and surgery (82%) vs. surgery alone (53%) [34].